In vitro assessment of deferoxamine on mesenchymal stromal cells from tumor and bone marrow

被引:13
作者
Wang, Guoping
Shen, Guobo
Yin, Tao [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Peoples South Rd Three Sect 17, Chengdu 610041, Peoples R China
[2] Collaborat Innovat Ctr Biotherapy, Peoples South Rd Three Sect 17, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
Deferoxamine; Mesenchymal stromal cells; ICAM-1; VCAM-1; IRON CHELATION; STEM-CELLS; DESFERRIOXAMINE; ICAM-1; APOPTOSIS; TOXICITY; SURVIVAL; PHARMACOKINETICS; FERRIOXAMINE; PROTECTS;
D O I
10.1016/j.etap.2016.11.014
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Deferoxamine (DFO), an iron chelator, is commonly used to remove excess iron from the body. DFO has also been demonstrated to have anti-tumor effect. However, there is no available report on the effect of deferoxamine on mesenchymal stromal cells (MSCs). In this study, we first isolated tumor-associated MSCs (TAMSCs) from EG-7 tumors, which were positive for CD29, CD44, CD73, CD90 and CD105. Ex vivo cultured stem cells derived from tumor and bone marrow compartment were exposed to DFO. We demonstrated that DFO had growth-arresting and apoptosis-inducing effect on TAMSCs and bone marrow MSCs (BMMSCs). DFO also influenced the expression pattern of adhesion molecule VCAM-1 on both TAMSCs and BMMSCs. Notwithstanding its widespread use, our results here warrants caution in the application of DFO, and also highlights the need for careful evaluation of the bone marrow compartment in patients receiving DFO treatment. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 35 条
[21]   SYNTHESES AND THERAPEUTIC POTENTIAL OF HYDROXAMIC ACID BASED SIDEROPHORES AND ANALOGS [J].
MILLER, MJ .
CHEMICAL REVIEWS, 1989, 89 (07) :1563-1579
[22]   Deferoxamine pretreatment prevents Cr(VI)-induced nephrotoxicity and oxidant stress: Role of Cr(VI) chelation [J].
Molina-Jijon, Eduardo ;
Zarco-Marquez, Guillermo ;
Noel Medina-Campos, Omar ;
Lucia Zatarain-Barron, Zyanya ;
Hernandez-Pando, Rogelio ;
Pinzon, Enrique ;
Marina Zavaleta, Rosa ;
Tapia, Edilia ;
Pedraza-Chaverri, Jose .
TOXICOLOGY, 2012, 291 (1-3) :93-101
[23]   Deferoxamine enhances anti-proliferative effect of interferon-γ against hepatocellular carcinoma cells [J].
Okada, Toshie ;
Sawada, Tokihiko ;
Kubota, Kefichi .
CANCER LETTERS, 2007, 248 (01) :24-31
[24]   ICAM-1 regulates the survival of influenza virus in lung epithelial cells during the early stages of infection [J].
Othumpangat, Sreekumar ;
Noti, John D. ;
McMillen, Cynthia M. ;
Beezhold, Donald H. .
VIROLOGY, 2016, 487 :85-94
[25]   Vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) provide co-stimulation in positive selection along with survival of selected thyrnocytes [J].
Paessens, Lutz C. ;
Singh, Satwinder K. ;
Fernandes, Rosette J. ;
van Kooyk, Yvette .
MOLECULAR IMMUNOLOGY, 2008, 45 (01) :42-48
[26]   An update on iron chelation therapy [J].
Poggiali, Erika ;
Cassinerio, Elena ;
Zanaboni, Laura ;
Cappellini, Maria Domenica .
BLOOD TRANSFUSION, 2012, 10 (04) :411-422
[27]   Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats [J].
Ram, Mahendra ;
Singh, Vishakha ;
Kumawat, Sanjay ;
Kumar, Dhirendra ;
Lingaraju, Madhu C. ;
Singh, Thakur Uttam ;
Rahal, Anti ;
Tandan, Surendra Kumar ;
Kumar, Dinesh .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 764 :9-21
[28]   CCR2-Dependent Recruitment of Macrophages by Tumor-Educated Mesenchymal Stromal Cells Promotes Tumor Development and Is Mimicked by TNFα [J].
Ren, Guangwen ;
Zhao, Xin ;
Wang, Ying ;
Zhang, Xin ;
Chen, Xiaodong ;
Xu, Chunliang ;
Yuan, Zeng-rong ;
Roberts, Arthur I. ;
Zhang, Liying ;
Zheng, Betty ;
Wen, Ting ;
Han, Yanyan ;
Rabson, Arnold B. ;
Tischfield, Jay A. ;
Shao, Changshun ;
Shi, Yufang .
CELL STEM CELL, 2012, 11 (06) :812-824
[29]   Evaluation of the use of human Mesenchymal Stem Cells for acute toxicity tests [J].
Scanu, M. ;
Mancuso, L. ;
Cao, G. .
TOXICOLOGY IN VITRO, 2011, 25 (08) :1989-1995
[30]   STUDIES IN DESFERRIOXAMINE AND FERRIOXAMINE METABOLISM IN NORMAL AND IRON-LOADED SUBJECTS [J].
SUMMERS, MR ;
JACOBS, A ;
TUDWAY, D ;
PERERA, P ;
RICKETTS, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1979, 42 (04) :547-555